Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hepatorenal Syndrome | 1 | 2018 | 76 | 0.560 |
Why?
|
Mastocytosis, Systemic | 1 | 2018 | 103 | 0.530 |
Why?
|
Liver Failure | 1 | 2018 | 250 | 0.510 |
Why?
|
Liver Transplantation | 7 | 2023 | 2330 | 0.500 |
Why?
|
Clinical Clerkship | 3 | 2024 | 564 | 0.390 |
Why?
|
Calpain | 4 | 2006 | 146 | 0.390 |
Why?
|
Ascites | 1 | 2013 | 338 | 0.380 |
Why?
|
Kidney Transplantation | 7 | 2018 | 4235 | 0.380 |
Why?
|
SKP Cullin F-Box Protein Ligases | 3 | 2006 | 175 | 0.370 |
Why?
|
Death | 2 | 2011 | 676 | 0.340 |
Why?
|
Hernia, Ventral | 1 | 2013 | 218 | 0.340 |
Why?
|
Muscle Proteins | 5 | 2006 | 1154 | 0.320 |
Why?
|
Students, Medical | 4 | 2024 | 1936 | 0.320 |
Why?
|
Tissue and Organ Harvesting | 1 | 2011 | 373 | 0.300 |
Why?
|
Glycogen Synthase Kinase 3 | 2 | 2005 | 411 | 0.270 |
Why?
|
Muscle Fibers, Skeletal | 3 | 2005 | 542 | 0.260 |
Why?
|
Cutaneous Fistula | 1 | 2006 | 79 | 0.250 |
Why?
|
General Surgery | 3 | 2024 | 1692 | 0.250 |
Why?
|
Muscular Atrophy | 2 | 2006 | 334 | 0.250 |
Why?
|
Kidney Failure, Chronic | 1 | 2018 | 2472 | 0.250 |
Why?
|
Intestinal Fistula | 1 | 2006 | 142 | 0.240 |
Why?
|
Tissue Donors | 2 | 2011 | 2332 | 0.240 |
Why?
|
Hyperparathyroidism, Primary | 1 | 2006 | 163 | 0.230 |
Why?
|
Liver Cirrhosis | 3 | 2021 | 1935 | 0.230 |
Why?
|
Living Donors | 3 | 2023 | 641 | 0.220 |
Why?
|
Tissue and Organ Procurement | 1 | 2011 | 962 | 0.210 |
Why?
|
Sepsis | 3 | 2006 | 2585 | 0.210 |
Why?
|
Ubiquitin-Protein Ligases | 3 | 2006 | 1899 | 0.200 |
Why?
|
Dexamethasone | 3 | 2006 | 1948 | 0.200 |
Why?
|
Muscles | 1 | 2006 | 1576 | 0.190 |
Why?
|
Graft Survival | 4 | 2018 | 3820 | 0.190 |
Why?
|
Endovascular Procedures | 3 | 2021 | 2183 | 0.180 |
Why?
|
Drug Costs | 1 | 2018 | 1183 | 0.170 |
Why?
|
Clinical Enzyme Tests | 1 | 2020 | 113 | 0.170 |
Why?
|
Diagnostic Errors | 1 | 2007 | 1265 | 0.170 |
Why?
|
Aspartate Aminotransferases | 1 | 2020 | 416 | 0.150 |
Why?
|
Hepatic Artery | 1 | 2018 | 232 | 0.140 |
Why?
|
Platelet Count | 1 | 2020 | 781 | 0.140 |
Why?
|
Immunosuppressive Agents | 2 | 2018 | 4176 | 0.140 |
Why?
|
Gynecology | 1 | 2022 | 526 | 0.140 |
Why?
|
Adenoma | 1 | 2007 | 2163 | 0.130 |
Why?
|
Graft Rejection | 2 | 2018 | 4446 | 0.130 |
Why?
|
Obstetrics | 1 | 2022 | 666 | 0.130 |
Why?
|
Bullying | 1 | 2018 | 232 | 0.120 |
Why?
|
Calcium | 2 | 2006 | 5722 | 0.120 |
Why?
|
Graft Occlusion, Vascular | 1 | 2018 | 537 | 0.120 |
Why?
|
Education, Medical, Undergraduate | 2 | 2024 | 1070 | 0.120 |
Why?
|
Aortic Aneurysm | 1 | 2020 | 648 | 0.120 |
Why?
|
Specialties, Surgical | 1 | 2019 | 389 | 0.120 |
Why?
|
Angioplasty, Balloon | 1 | 2018 | 589 | 0.120 |
Why?
|
End Stage Liver Disease | 1 | 2018 | 352 | 0.110 |
Why?
|
Blood Group Incompatibility | 1 | 2015 | 135 | 0.110 |
Why?
|
Thyroid Neoplasms | 1 | 2007 | 2332 | 0.110 |
Why?
|
Postoperative Complications | 4 | 2021 | 15633 | 0.110 |
Why?
|
Blood Vessel Prosthesis Implantation | 2 | 2021 | 1428 | 0.110 |
Why?
|
Donor Selection | 1 | 2015 | 232 | 0.110 |
Why?
|
Learning | 2 | 2020 | 1740 | 0.100 |
Why?
|
ABO Blood-Group System | 1 | 2015 | 380 | 0.100 |
Why?
|
Laparotomy | 1 | 2014 | 457 | 0.100 |
Why?
|
Antilymphocyte Serum | 1 | 2013 | 487 | 0.100 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2021 | 1228 | 0.090 |
Why?
|
Delayed Graft Function | 1 | 2011 | 54 | 0.090 |
Why?
|
Muscle, Skeletal | 5 | 2006 | 4948 | 0.090 |
Why?
|
Cold Ischemia | 1 | 2011 | 71 | 0.090 |
Why?
|
Emergencies | 2 | 2014 | 1217 | 0.090 |
Why?
|
Organ Transplantation | 1 | 2019 | 1157 | 0.080 |
Why?
|
Curriculum | 2 | 2022 | 3743 | 0.080 |
Why?
|
Blood Platelets | 1 | 2020 | 2479 | 0.080 |
Why?
|
Thiadiazoles | 2 | 2005 | 63 | 0.080 |
Why?
|
Lithium Chloride | 2 | 2005 | 82 | 0.080 |
Why?
|
Steroids | 1 | 2013 | 929 | 0.080 |
Why?
|
Male | 25 | 2021 | 360846 | 0.080 |
Why?
|
Treatment Outcome | 10 | 2020 | 64685 | 0.080 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2015 | 2009 | 0.080 |
Why?
|
Retrospective Studies | 12 | 2021 | 80647 | 0.070 |
Why?
|
Intraoperative Complications | 1 | 2014 | 1166 | 0.070 |
Why?
|
Middle Aged | 15 | 2019 | 220921 | 0.070 |
Why?
|
Carcinoma, Medullary | 1 | 2007 | 115 | 0.070 |
Why?
|
Perfusion | 1 | 2011 | 1373 | 0.070 |
Why?
|
Waiting Lists | 1 | 2011 | 765 | 0.070 |
Why?
|
Italy | 1 | 2018 | 842 | 0.070 |
Why?
|
Humans | 28 | 2024 | 761596 | 0.060 |
Why?
|
Glucocorticoids | 2 | 2005 | 2161 | 0.060 |
Why?
|
Lower Extremity | 1 | 2013 | 1202 | 0.060 |
Why?
|
Risk Assessment | 4 | 2021 | 23996 | 0.060 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 1 | 2005 | 102 | 0.060 |
Why?
|
Water-Electrolyte Balance | 1 | 2006 | 325 | 0.060 |
Why?
|
Drug Administration Schedule | 2 | 2018 | 4853 | 0.060 |
Why?
|
Ischemia | 1 | 2013 | 1884 | 0.060 |
Why?
|
Enzyme Inhibitors | 2 | 2005 | 3713 | 0.060 |
Why?
|
Thyroidectomy | 2 | 2007 | 908 | 0.060 |
Why?
|
Nutritional Support | 1 | 2006 | 173 | 0.060 |
Why?
|
Rats, Sprague-Dawley | 5 | 2006 | 8181 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2018 | 4016 | 0.060 |
Why?
|
Transplantation Tolerance | 1 | 2018 | 605 | 0.050 |
Why?
|
Calcium-Binding Proteins | 2 | 2006 | 1069 | 0.050 |
Why?
|
Aged | 12 | 2020 | 169310 | 0.050 |
Why?
|
Female | 19 | 2021 | 392705 | 0.050 |
Why?
|
Length of Stay | 2 | 2014 | 6426 | 0.050 |
Why?
|
Cost Savings | 1 | 2018 | 913 | 0.050 |
Why?
|
Fetal Diseases | 1 | 2008 | 913 | 0.050 |
Why?
|
Phosphates | 1 | 2006 | 770 | 0.050 |
Why?
|
Positron-Emission Tomography | 3 | 2015 | 6484 | 0.050 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2015 | 2297 | 0.050 |
Why?
|
RNA, Messenger | 3 | 2006 | 12794 | 0.050 |
Why?
|
Biopsy, Fine-Needle | 1 | 2007 | 1118 | 0.050 |
Why?
|
Peptide Hydrolases | 1 | 2005 | 624 | 0.050 |
Why?
|
Time Factors | 6 | 2020 | 39969 | 0.050 |
Why?
|
Proteasome Endopeptidase Complex | 2 | 2006 | 1321 | 0.050 |
Why?
|
Carcinoma, Papillary | 1 | 2007 | 785 | 0.050 |
Why?
|
Spinal Neoplasms | 1 | 2008 | 716 | 0.050 |
Why?
|
Caspases | 1 | 2004 | 879 | 0.050 |
Why?
|
Prenatal Diagnosis | 1 | 2008 | 1265 | 0.050 |
Why?
|
Patient Acceptance of Health Care | 1 | 2015 | 3206 | 0.050 |
Why?
|
Boston | 4 | 2015 | 9327 | 0.040 |
Why?
|
Cost-Benefit Analysis | 2 | 2018 | 5493 | 0.040 |
Why?
|
Drainage | 1 | 2006 | 1157 | 0.040 |
Why?
|
Neuroblastoma | 1 | 2008 | 1250 | 0.040 |
Why?
|
Ubiquitin | 1 | 2005 | 839 | 0.040 |
Why?
|
Parathyroid Hormone | 1 | 2006 | 1803 | 0.040 |
Why?
|
Adult | 12 | 2020 | 221210 | 0.040 |
Why?
|
Risk Factors | 7 | 2021 | 74213 | 0.040 |
Why?
|
Databases, Factual | 2 | 2020 | 7968 | 0.040 |
Why?
|
Gene Expression | 3 | 2006 | 7581 | 0.040 |
Why?
|
Liver Neoplasms | 1 | 2015 | 4317 | 0.040 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2023 | 474 | 0.040 |
Why?
|
Rats | 5 | 2006 | 23741 | 0.040 |
Why?
|
Thyroid Nodule | 1 | 2005 | 764 | 0.040 |
Why?
|
Awareness | 1 | 2022 | 648 | 0.040 |
Why?
|
Internship and Residency | 1 | 2018 | 5882 | 0.040 |
Why?
|
Glycoproteins | 1 | 2006 | 2203 | 0.040 |
Why?
|
Angiography | 1 | 2023 | 1595 | 0.040 |
Why?
|
Radiopharmaceuticals | 3 | 2015 | 2650 | 0.040 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2005 | 1935 | 0.040 |
Why?
|
Angiography, Digital Subtraction | 1 | 2018 | 335 | 0.040 |
Why?
|
Kidney | 1 | 2012 | 7048 | 0.030 |
Why?
|
Bacterial Infections | 1 | 2004 | 1391 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 3 | 2015 | 20568 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2005 | 18966 | 0.030 |
Why?
|
Operating Rooms | 1 | 2022 | 789 | 0.030 |
Why?
|
Vascular Patency | 1 | 2018 | 911 | 0.030 |
Why?
|
Cysteine Proteinase Inhibitors | 2 | 2006 | 188 | 0.030 |
Why?
|
Constriction, Pathologic | 1 | 2018 | 1096 | 0.030 |
Why?
|
Mentors | 1 | 2020 | 661 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2023 | 20100 | 0.030 |
Why?
|
Perception | 1 | 2020 | 1197 | 0.030 |
Why?
|
Burns | 1 | 2005 | 1882 | 0.030 |
Why?
|
Qualitative Research | 1 | 2024 | 3025 | 0.030 |
Why?
|
Intraoperative Period | 1 | 2014 | 510 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2005 | 10766 | 0.030 |
Why?
|
Dipeptides | 2 | 2006 | 391 | 0.030 |
Why?
|
Animals | 7 | 2013 | 168475 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2007 | 12973 | 0.020 |
Why?
|
Retreatment | 1 | 2013 | 598 | 0.020 |
Why?
|
Limb Salvage | 1 | 2013 | 481 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2024 | 3889 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2020 | 15266 | 0.020 |
Why?
|
Primary Graft Dysfunction | 1 | 2011 | 111 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2759 | 0.020 |
Why?
|
Mortality | 1 | 2021 | 2902 | 0.020 |
Why?
|
Age Distribution | 1 | 2015 | 2879 | 0.020 |
Why?
|
Enzyme Activation | 2 | 2005 | 3597 | 0.020 |
Why?
|
Apoptosis | 1 | 2005 | 9490 | 0.020 |
Why?
|
Fetal Movement | 1 | 2008 | 21 | 0.020 |
Why?
|
Models, Biological | 1 | 2005 | 9469 | 0.020 |
Why?
|
Survival Rate | 2 | 2014 | 12723 | 0.020 |
Why?
|
Transcription Factors | 2 | 2005 | 12130 | 0.020 |
Why?
|
Reoperation | 1 | 2018 | 4303 | 0.020 |
Why?
|
Creatinine | 1 | 2013 | 1899 | 0.020 |
Why?
|
Renal Insufficiency | 1 | 2013 | 809 | 0.020 |
Why?
|
Rabbits | 1 | 2013 | 4772 | 0.020 |
Why?
|
Self Report | 1 | 2018 | 3725 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2005 | 11904 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 3597 | 0.020 |
Why?
|
Stents | 1 | 2018 | 3179 | 0.020 |
Why?
|
Pepstatins | 1 | 2006 | 10 | 0.020 |
Why?
|
Comorbidity | 1 | 2021 | 10508 | 0.020 |
Why?
|
Spinal Cord Compression | 1 | 2008 | 235 | 0.020 |
Why?
|
CCAAT-Enhancer-Binding Protein-delta | 1 | 2005 | 26 | 0.020 |
Why?
|
Myoblasts, Skeletal | 1 | 2006 | 75 | 0.020 |
Why?
|
Young Adult | 3 | 2020 | 59260 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2018 | 39106 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2013 | 2178 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 3415 | 0.010 |
Why?
|
Reperfusion Injury | 1 | 2011 | 1023 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2015 | 4915 | 0.010 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2005 | 286 | 0.010 |
Why?
|
Toes | 1 | 2005 | 209 | 0.010 |
Why?
|
Prognosis | 2 | 2015 | 29629 | 0.010 |
Why?
|
Cause of Death | 1 | 2014 | 3683 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2008 | 1626 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15843 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6484 | 0.010 |
Why?
|
Hindlimb | 1 | 2005 | 513 | 0.010 |
Why?
|
Liver | 1 | 2018 | 7528 | 0.010 |
Why?
|
Recurrence | 1 | 2015 | 8466 | 0.010 |
Why?
|
Caspase 3 | 1 | 2004 | 731 | 0.010 |
Why?
|
Hydrogen Peroxide | 1 | 2006 | 730 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2020 | 58984 | 0.010 |
Why?
|
Recovery of Function | 1 | 2012 | 2979 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8833 | 0.010 |
Why?
|
Delivery, Obstetric | 1 | 2008 | 941 | 0.010 |
Why?
|
Critical Illness | 1 | 2013 | 2723 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2014 | 5293 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2023 | 36426 | 0.010 |
Why?
|
Ultrasonography, Prenatal | 1 | 2008 | 1755 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12059 | 0.010 |
Why?
|
Patient Selection | 1 | 2012 | 4244 | 0.010 |
Why?
|
Gestational Age | 1 | 2008 | 3577 | 0.010 |
Why?
|
Oligopeptides | 1 | 2004 | 1187 | 0.010 |
Why?
|
Survival Analysis | 1 | 2011 | 10090 | 0.010 |
Why?
|
Transfection | 1 | 2006 | 5774 | 0.010 |
Why?
|
Forkhead Transcription Factors | 1 | 2005 | 1616 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2005 | 2457 | 0.010 |
Why?
|
Up-Regulation | 1 | 2005 | 4125 | 0.010 |
Why?
|
Incidence | 1 | 2014 | 21355 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2005 | 2865 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2012 | 7391 | 0.010 |
Why?
|
Algorithms | 1 | 2015 | 14033 | 0.010 |
Why?
|
Phosphorylation | 1 | 2005 | 8321 | 0.010 |
Why?
|
Quality of Life | 1 | 2015 | 13367 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2008 | 11120 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2005 | 4514 | 0.010 |
Why?
|
Cohort Studies | 1 | 2015 | 41495 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2005 | 4415 | 0.010 |
Why?
|
Cell Line | 1 | 2006 | 15601 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2005 | 14665 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2005 | 9001 | 0.000 |
Why?
|
Infant, Newborn | 1 | 2008 | 26202 | 0.000 |
Why?
|
DNA-Binding Proteins | 1 | 2005 | 9610 | 0.000 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2008 | 11742 | 0.000 |
Why?
|
Adolescent | 1 | 2015 | 88326 | 0.000 |
Why?
|
Pregnancy | 1 | 2008 | 29890 | 0.000 |
Why?
|